FDA Warning Letter — Exxon

Case 685811 — FEI 3013692249

The FDA took a Warning Letter action against Exxon on Jun 4, 2024 (Fountain Inn, SC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Exxon
Date
Jun 4, 2024
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Fountain Inn, SC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.